Validation of a hierarchical algorithm to define chronic liver disease and cirrhosis etiology in administrative healthcare data
Open Access
- 18 February 2020
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 15 (2) , e0229218
Abstract
Chronic liver disease (CLD) and cirrhosis are leading causes of death globally with the burden of disease rising significantly over the past several decades. Defining the etiology of liver disease is important for understanding liver disease epidemiology, healthcare planning, and outcomes. The aim of this study was to validate a hierarchical algorithm for CLD and cirrhosis etiology in administrative healthcare data. Consecutive patients with CLD or cirrhosis attending an outpatient hepatology clinic in Ontario, Canada from 05/01/2013–08/31/2013 underwent detailed chart abstraction. Gold standard liver disease etiology was determined by an attending hepatologist as hepatitis C (HCV), hepatitis B (HBV), alcohol-related, non-alcoholic fatty liver disease (NAFLD)/cryptogenic, autoimmune or hemochromatosis. Individual data was linked to routinely collected administrative healthcare data at ICES. Diagnostic accuracy of a hierarchical algorithm incorporating both laboratory and administrative codes to define etiology was evaluated by calculating sensitivity, specificity, positive (PPV) and negative predictive values (NPV), and kappa’s agreement. 442 individuals underwent chart abstraction (median age 53 years, 53% cirrhosis, 45% HCV, 26% NAFLD, 10% alcohol-related). In patients with cirrhosis, the algorithm had adequate sensitivity/PPV (>75%) and excellent specificity/NPV (>90%) for all etiologies. In those without cirrhosis, the algorithm was excellent for all etiologies except for hemochromatosis and autoimmune diseases. A hierarchical algorithm incorporating laboratory and administrative coding can accurately define cirrhosis etiology in routinely collected healthcare data. These results should facilitate health services research in this growing patient population.Keywords
Funding Information
- American Association for the Study of Liver Diseases (CTORA)
- Southeastern Ontario Academic Medical Organization (NCSP)
This publication has 16 references indexed in Scilit:
- Trends in Burden of Cirrhosis and Hepatocellular Carcinoma by Underlying Liver Disease in US Veterans, 2001–2013Gastroenterology, 2015
- Coding algorithms for identifying patients with cirrhosis and hepatitis B or C virus using administrative dataPharmacoepidemiology and Drug Safety, 2014
- Nonalcoholic fatty liver disease (NAFLD) in the Veterans Administration population: development and validation of an algorithm for NAFLD using automated dataAlimentary Pharmacology & Therapeutics, 2014
- Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010The Lancet, 2012
- Validity of administrative data for the diagnosis of primary sclerosing cholangitis: a population-based studyLiver International, 2011
- Validation of Coding Algorithms for the Identification of Patients with Primary Biliary Cirrhosis Using Administrative DataCanadian Journal of Gastroenterology and Hepatology, 2010
- The validity of viral hepatitis and chronic liver disease diagnoses in Veterans Affairs administrative databasesAlimentary Pharmacology & Therapeutics, 2007
- Age- and sex-specific income gradients in alcohol-related hospitalization rates in an urban areaAnnals of Epidemiology, 2005
- Evaluation of Abnormal Liver-Enzyme Results in Asymptomatic PatientsNew England Journal of Medicine, 2000
- Cryptogenic Cirrhosis: Clinical Characterization and Risk Factors for Underlying DiseaseHepatology, 1999